ASCO 2017 Preview: A Panel Discussion of Clinical Presentations with Practice-Changing Potential

About Conisus

A free one hour webinar brought to you by Conisus LLC. Conisus is a leading provider of strategic medical communication services to the biopharmaceutical industry. We are dedicated to improving the care of patients with serious or life-threatening conditions by delivering superior medical education programs to healthcare professionals. Our goal is to provide best-in-class strategic services while demonstrating unrivaled service to healthcare professionals, clients, and educational supporters, ensuring that all operations reflect the highest degree of integrity.

ASCO 2017 Preview: A Panel Discussion of Clinical Presentations with Practice-Changing Potential

Conisus has identified several pivotal presentations at the upcoming American Society of Clinical Oncology (ASCO) annual meeting that have the potential to significantly alter treatment paradigms in cancer care. This webinar will feature an expert panel who will discuss these clinically meaningful presentations. Information will be presented in a roundtable format that will offer clinical, commercial and financial perspectives followed by a Q&A session.

Thursday May 25 at 12PM ET

Panelists:

Richard Leff, MD
Chief Medical Officer
Conisus LLC

Michael King
Managing Director and Senior Biotechnology Analyst
JMP Securities

Lee S. Schwartzberg, MD, FACP
Chief, Division of Hematology Oncology
The University of Tennessee Health Science Center

Moderated By:

Don Sharpe
President
OBR